Top Markets
#1 Verus Coin Verus Coin +19.70%
#2 Fake World Assets Fake World Assets +11.59%
#3 GoPlus Security GoPlus Security +4.67%
#4 Everything Everything +3.70%
#5 TronBank TronBank +3.67%
#6 TENDIES TENDIES +3.27%
#7 Tutorial Tutorial +3.00%
#8 Bedrock Bedrock +2.68%
#9 Janction Janction +2.16%
#10 Holoworld Holoworld +2.14%
Coin of the day
Verus Coin Verus Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rang in Aktien #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aktienkurs
$0.617
Zuletzt synchronisiert: 2024-10-14
Marktkapitalisierung
$6.13M
Veränderung (1 Tag)
0.49%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Kategorie

Healthcare
P/B-Verhältnis für Kineta, Inc. (KA)
P/B-Verhältnis zum August 2026 TTM: -0.58
Laut den neuesten Finanzberichten und dem Aktienkurs von Kineta, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) -0.58. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 13.88.
P/B-Verlauf für Kineta, Inc. von 2015 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -1,197.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -1,180.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -698.93%
BE